Mustang Bio, Inc. financial data

Symbol
MBIO on Nasdaq
Location
377 Plantation Street, Worcester, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 129 % +143%
Debt-to-equity 357 %
Return On Equity -75.3 % -118%
Return On Assets -16.5 % +91.5%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 14.8M USD -61.8%
Weighted Average Number of Shares Outstanding, Basic 6.24M shares +766%
Weighted Average Number of Shares Outstanding, Diluted 6.24M shares +766%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 2.74M USD -58.1%
Operating Income (Loss) -2.78M USD +88.4%
Nonoperating Income (Expense) 444K USD -19.7%
Net Income (Loss) Attributable to Parent -2.34M USD +90%
Earnings Per Share, Basic 6 USD/shares +96.4%
Earnings Per Share, Diluted 6 USD/shares +96.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19M USD +439%
Assets, Current 19.4M USD +220%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 0 USD -100%
Assets 19.4M USD +169%
Accounts Payable, Current 4.99M USD -43%
Liabilities, Current 9.44M USD -37.2%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 9.59M USD -39.5%
Retained Earnings (Accumulated Deficit) -398M USD -0.59%
Stockholders' Equity Attributable to Parent 9.77M USD
Liabilities and Equity 19.4M USD +169%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.39M USD +73.9%
Net Cash Provided by (Used in) Financing Activities 7.62M USD
Net Cash Provided by (Used in) Investing Activities 1.17M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 7.32M shares -93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19M USD +387%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 152M USD +2.99%
Deferred Tax Assets, Gross 152M USD +2.6%
Operating Lease, Liability 0 USD -100%
Depreciation 420K USD -69.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 955K USD -68.6%
Property, Plant and Equipment, Gross 7.69M USD 0%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 439K USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 516K USD -28.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 77K USD -85.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 269K USD -61.7%
Deferred Tax Assets, Operating Loss Carryforwards 95.1M USD +12.4%
Preferred Stock, Shares Issued 250K shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 274K USD +1.86%
Operating Lease, Payments 86K USD -44.9%
Preferred Stock, Shares Outstanding 250K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 30K USD -94.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%